Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06981156 · ClinicalTrials.gov registry record
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
A clinical trial of Pediatric Brain Tumor and Pediatric Spine Tumor, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06981156: Recruiting study of Pediatric Brain Tumor and Pediatric Spine Tumor, sponsored by University of Wisconsin, Madison.
NCT06981156 is a study of Pediatric Brain Tumor and Pediatric Spine Tumor that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 75 participants, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (103% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06981156, a study of Pediatric Brain Tumor and Pediatric Spine Tumor, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.
Primary Outcome
The Pediatric Neurologic Assessment in Neuro-Oncology (pNANO) is scored in multiple domains: - strength, level of consciousness, and gait domains (each individually scored 0-3) * facial strength, cerebellar function, visual fields, extraocular movements, dysphagia, and dysarthria domains (each individually scored 0-2) * visual acuity domain scored from 0-1 If summed, cumulative scores range from 0 (normal) to 22 (inability to function in each relevant domain) Investigators will explore variabi
Conditions Studied
Interventions
- DIAGNOSTIC_TEST pNANO Assessment
Study Locations (1)
Wisconsin
- American Family Children's Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2027-01 |
What NCT06981156 shows while recruiting
NCT06981156 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 37-participant average among 9 other Pediatric Brain Tumor trials with a reported enrollment target (103% higher).
The record links to 2 conditions, with Pediatric Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which pNANO Assessment is the first listed.
NCT06981156 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06981156 about?
NCT06981156 is a clinical study titled "Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)". This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.
What is the current status of trial NCT06981156?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2025-05-13. Estimated completion is 2027-01.
What conditions does trial NCT06981156 study?
This clinical trial studies the following conditions: Pediatric Brain Tumor, Pediatric Spine Tumor.
What interventions are being tested in trial NCT06981156?
The interventions under investigation include: pNANO Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06981156?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06981156 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06981156's enrollment target sits among peer trials
75 1st of 9 higher than 9 of 9 other Pediatric Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Survivors Journey+
RECRUITING · NA
-
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
RECRUITING · Phase 1
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
RECRUITING · Phase 1
-
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
RECRUITING · NA
-
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI